Radiation Oncology Device Approval in the United States and Canada.
PMID: 31192056 ·
C, r, a, i, g, , A, , B, e, e, r, s, ;, , W, e, n, d, y, , L, , S, m, i, t, h, ;, , S, a, r, a, h, , W, e, p, p, l, e, r, ;, , C, o, l, l, e, e, n, , S, c, h, i, n, k, e, l, ;, , H, a, r, v, e, y, , Q, u, o, n
Реклама
Аннотация
Background Medical devices are a crucial component in the field of radiation oncology. The review and licensing of radiation oncology devices (RODs) is managed on a national basis in Canada by Health Canada and in the United States by the Food and Drug Administration (FDA). The purpose of this study was to examine differences in ROD licensing timelines between Health Canada and the FDA that may impact the ability of Canadians to access the most up-to-date radiation oncology care. Methods A list
Реклама
Официальный источник
Открыть в PubMed →Данные получены из PubMed / NCBI. Полный текст и наиболее актуальную информацию всегда смотрите в официальной записи.